Royal Bank of Canada Forecasts Strong Price Appreciation for Omega Healthcare Investors (NYSE:OHI) Stock

Omega Healthcare Investors (NYSE:OHI) had its target price raised by equities researchers at Royal Bank of Canada from $39.00 to $43.00 in a research note issued on Monday,Benzinga reports. The brokerage currently has a “sector perform” rating on the real estate investment trust’s stock. Royal Bank of Canada’s price objective would indicate a potential upside of 3.64% from the company’s previous close.

A number of other research analysts have also recently commented on OHI. Truist Financial upped their price objective on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “hold” rating in a report on Wednesday, September 4th. Scotiabank increased their price target on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a report on Monday, August 26th. Berenberg Bank started coverage on shares of Omega Healthcare Investors in a report on Friday, October 18th. They issued a “buy” rating and a $45.00 price objective on the stock. Wells Fargo & Company reaffirmed an “overweight” rating and set a $43.00 target price (up previously from $40.00) on shares of Omega Healthcare Investors in a research note on Tuesday, October 1st. Finally, BMO Capital Markets increased their price objective on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the stock a “market perform” rating in a research report on Monday, October 7th. Seven analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $40.00.

Omega Healthcare Investors Trading Up 0.3 %

OHI stock traded up $0.14 during trading on Monday, reaching $41.49. 316,915 shares of the stock were exchanged, compared to its average volume of 1,663,934. The company has a current ratio of 6.48, a quick ratio of 6.48 and a debt-to-equity ratio of 1.10. The firm has a market capitalization of $11.20 billion, a price-to-earnings ratio of 30.54, a P/E/G ratio of 1.33 and a beta of 0.99. The business has a 50 day moving average price of $40.59 and a 200-day moving average price of $36.40. Omega Healthcare Investors has a 1 year low of $27.53 and a 1 year high of $44.42.

Insider Activity

In related news, CFO Robert O. Stephenson sold 22,542 shares of the company’s stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the sale, the chief financial officer now directly owns 183,076 shares in the company, valued at approximately $7,357,824.44. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Omega Healthcare Investors news, COO Daniel J. Booth sold 56,725 shares of Omega Healthcare Investors stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the completion of the sale, the chief operating officer now directly owns 100,000 shares of the company’s stock, valued at $4,025,000. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Robert O. Stephenson sold 22,542 shares of the stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.19, for a total value of $905,962.98. Following the completion of the transaction, the chief financial officer now owns 183,076 shares in the company, valued at approximately $7,357,824.44. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.37% of the company’s stock.

Institutional Investors Weigh In On Omega Healthcare Investors

Institutional investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. lifted its position in shares of Omega Healthcare Investors by 0.5% during the 1st quarter. Vanguard Group Inc. now owns 35,379,787 shares of the real estate investment trust’s stock worth $1,120,478,000 after buying an additional 165,105 shares during the last quarter. Caxton Associates LP purchased a new stake in Omega Healthcare Investors in the second quarter valued at $1,652,000. Cetera Advisors LLC acquired a new position in Omega Healthcare Investors in the first quarter valued at $646,000. Van ECK Associates Corp grew its holdings in shares of Omega Healthcare Investors by 15.4% during the third quarter. Van ECK Associates Corp now owns 100,145 shares of the real estate investment trust’s stock worth $4,167,000 after purchasing an additional 13,367 shares during the last quarter. Finally, Handelsbanken Fonder AB increased its position in shares of Omega Healthcare Investors by 24.1% during the third quarter. Handelsbanken Fonder AB now owns 64,913 shares of the real estate investment trust’s stock worth $2,642,000 after purchasing an additional 12,600 shares in the last quarter. Hedge funds and other institutional investors own 65.25% of the company’s stock.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.